Kawasaki, Japan

Yumiko Fukuda

This inventor holds 6 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Ea Pharma Co., Ltd.. Active years: 2002-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumiko Fukuda. Retrieved from https://idiyas.com/inventor/yumiko-fukuda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Kanagawa, JP (2004 - 2013)
  • Kawasaki, JP (2002 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yumiko Fukuda: Innovator in Diabetes Treatment

Introduction

Yumiko Fukuda is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of diabetes treatment, holding a total of six patents. Her innovative work focuses on developing remedies that target the underlying mechanisms of diabetes.

Latest Patents

Fukuda's latest patents include a method of screening compounds that have a hypoglycemic effect. This method specifically identifies hypoglycemic compounds capable of binding to the β subunit of a trimeric GTP-binding protein. The remedies she has developed are characterized by their novel function mechanisms, which enhance their effectiveness in managing diabetes.

Career Highlights

Throughout her career, Yumiko Fukuda has worked with notable companies such as Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. Her experience in these organizations has allowed her to refine her research and contribute to advancements in diabetes treatment.

Collaborations

Fukuda has collaborated with esteemed colleagues, including Masaru Takayanagi and Kazuyuki Sagi. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.

Conclusion

Yumiko Fukuda's work in diabetes treatment exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to improving the lives of those affected by diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…